Dysregulated Foxp3
+ Treg functions result in uncontrolled immune activation and autoimmunity. Therefore, identifying cellular factors modulating Treg functions is an area of great importance. Here, using Treg-specific Il27ra −/− mice, we report that IL-27 signaling in Foxp3 + Tregs is essential for Tregs to control autoimmune inflammation in the central nervous system (CNS). Following experimental autoimmune encephalomyelitis (EAE) induction, Treg-specific Il27ra −/− mice develop more severe EAE. Consistent with the severe disease, the numbers of IFNγ-and IL-17-producing CD4 T cells infiltrating the CNS tissues are greater in these mice. Treg accumulation in the inflamed CNS tissues is not affected by the lack of IL-27 signaling in Tregs, suggesting a functional defect of Il27ra
Tregs. IL-10 production by conventional CD4 T cells and their CNS accumulation are rather elevated in Treg-specific Il27ra −/− mice.
Analysis with Treg fate-mapping reporter mice further demonstrates that IL-27 signaling in Tregs may control stability of Foxp3 expression. Finally, systemic administration of recombinant IL-27 in Treg-specific Il27ra −/− mice fails to ameliorate the disease even in the presence of IL-27-responsive conventional CD4 T cells. These findings uncover a previously unknown role of IL-27 in regulating Treg function to control autoimmune inflammation. 
D efective Foxp3
+ regulatory CD4 T-cell (Treg) functions can result in uncontrolled autoimmune inflammation (1) . However, the cellular mechanisms underlying the defects remain largely unclear. Inflammatory mediators may undermine the Treg function (2), or alternatively, inflammatory effector T cells may resist Tregmediated suppression (3) . Understanding pathways regulating the Treg function to control inflammatory responses is thus a subject of great importance.
IL-27 is a heterodimeric cytokine composed of the p28 and Ebi3 subunits, produced by activated Ag-presenting cells (4) . It binds to IL-27 receptors (IL-27Rα:gp130) expressed on multiple cell types, including T lymphocytes (5) . IL-27 controls T-cell turnover under steady-state conditions, and T-cell responses elicited by TLR agonist-based vaccine adjuvant induced immune responses (6, 7) . In addition, IL-27 supports Th1 differentiation, inhibits Th17 differentiation, and induces IL-10-producing Foxp3 − CD4 T cells that are implicated in autoimmune regulation (8) (9) (10) . Indeed, Il27ra −/− mice are highly susceptible to experimental autoimmune encephalomyelitis (EAE), a myelin Ag-specific Th17-mediated autoimmunity in the central nervous system (CNS) (11, 12) . We recently uncovered a key role of IL-27 in supporting Foxp3
+ Treg function during T-cell-mediated intestinal inflammation (13), a model system in which Tregs are transferred into immunodeficient recipients. Thus, the exact role of IL-27 in Tregs under immunecompetent settings remains unclear.
Here, we generated Treg-specific Il27ra −/− mice using the CreLoxP system and examined the role of IL-27 signaling in Tregs during autoimmune inflammation. Following EAE induction, the onset and initial progression of the disease were comparable in wild-type and Treg-specific Il27ra −/− mice. However, the latter mice were unable to recover from the acute disease and developed a progressive form of the disease. Equivalent numbers of Tregs were found in the inflamed CNS tissues in both groups of mice, suggesting a functional defect of Tregs. Interestingly, the generation of IL-10 + CD4 T cells under these conditions remained unaffected. Fate-mapping reporter mice with Treg-specific IL-27Rα deficiency further demonstrated that IL-27 may control Treg stability. Importantly, systemic administration of IL-27 into Tregspecific Il27ra −/− mice did not attenuate the disease despite the presence of conventional CD4 T cells capable of responding to IL-27. Taken together, our results demonstrate an indispensable role for IL-27 in regulating Treg function during autoimmune inflammation.
Results
Treg-Specific Deletion of IL-27Rα Does Not Alter Treg Development.
To test the role of IL-27 in Tregs, we generated Treg-specific Il27ra −/− mice using the Cre-loxP system. Analogous to the
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Interleukin-27 (IL-27) can promote or antagonize inflammatory responses. However, the cellular mechanisms underlying such highly diverse roles remain unclear. It was proposed that IL-27 exerts antiinflammatory functions by directly acting on conventional CD4 T cells to induce IL-10-producing cells that are implicated in controlling inflammatory responses. Here, we have developed a Treg-specific IL-27Rα-deficient animal and observed that it is highly susceptible to autoimmune disease induction despite the presence of IL-10-producing T cells. We also show that systemic administration of IL-27 fails to attenuate ongoing inflammation in the absence of Treg expression of IL-27Rα. Therefore, IL-27 acting on Tregs plays a nonreplaceable role in controlling autoimmune inflammation, providing a rationale to develop a therapy by targeting IL-27 on Tregs.
germline Il27ra −/− mice (14) , exons 7 and 8, encoding a portion of the second fibronectin type III domain, were flanked by two loxP sites including the neomycin resistance cassette (Fig. 1A) . Mice with floxed Il27ra allele were then bred to FLP-recombinase transgenic mice, and mice carrying a floxed allele without the neomycin cassette were obtained (Fig. 1A) . Il27ra fl/fl mice were then crossed to the Foxp3
CreYFP mice to obtain Treg-specific Il27ra −/− (referred to as Treg
ΔIl27ra
) mice (Fig. 1A) . It was recently noted that the Cre activity of Foxp3
CreYFP mice could be promiscuous, and the Cre-mediated gene targeting can occur in non-Tregs (15) . PCR analysis of genomic DNA amplifying the targeted exons of the Il27ra gene validated Treg-specific deletion of exons 7 and 8 only in Tregs (Fig. S1) (Fig. 1B) . In vitro stimulation with IL-27 induced Il10, Ifng, and Tbx21 expression in conventional CD4 but not in Tregs from Treg ΔIl27ra mice (Fig. 1C) (14) . The total cellularity and the proportions of naive and effector/memory T cells in the thymus and periphery were comparable between the groups (Fig. 1D) . Expression of the Treg-associated markers CD25, GITR, and Neuropilin-1 (Nrp1) was also comparable (Fig. 1E) . Therefore, IL-27 signaling in Tregs seems dispensable for Treg development and homeostasis under steady-state conditions.
Treg-Specific Il27ra
−/− Mice Develop Severe EAE. Treg ΔIl27ra and Treg WT mice were induced for EAE by immunization with myelin oligodendrocyte glycoprotein (MOG) peptide 35-55 in complete Freund's adjuvant (CFA) followed by pertussis toxin injection. The onset and initial progression of the disease was similar between the groups ( Fig. 2A) . While the control Treg WT mice reached peak disease around day 17 and slowly recovered from the disease, Treg ΔIl27ra mice continuously exhibited signs of severe EAE ( Fig.  2A) . Histopathologic examination demonstrated that the spinal cords of the Treg ΔIl27ra mice were heavily infiltrated with inflammatory cells compared with the control mice that showed less severe inflammation (Fig. 2B ). The area of demyelination determined by Luxol fast blue (LFB) staining was substantially greater in Treg ΔIl27ra compared with that in control mice (Fig. 2C ). Germline Il27ra −/− mice develop severe EAE (12) . Interestingly, the progression of EAE in Treg ΔIl27ra mice after the peak of the disease was analogous to that in Il27ra −/− mice, although the clinical score of initial EAE induction (i.e., days 10-14) was markedly greater in Il27ra −/− mice ( Fig. 2A) . Consistently, the total numbers of CD4 T cells infiltrating the CNS were dramatically elevated in Treg
ΔIl27ra
, although CD4 T cells in the peripheral lymphoid tissues remained comparable (Fig. 2D ). T cells expressing the proinflammatory cytokines IFNγ or IL-17 were more abundant in the CNS tissues of Treg ΔIl27ra mice (Fig. 2E ). Brain cells stimulated with MOG peptide ex vivo secreted approximately twofold higher levels of IL-17 ( Fig. 2F) . We also noted that the level of IL-10-producing CNS infiltrating CD4 T cells was increased in Treg ΔIl27ra mice (Fig. 2G) ; however, IL-10 protein measured from the brain homogenates was comparable between the groups ( 
Severe EAE in Treg
ΔIl27ra mice could be attributed to elevated generation of MOG-specific effector cells in the draining lymph nodes. IFNγ-, IL-17-, and IL-10-producing CD4 T cells in the draining lymphoid tissues were thus measured at different time points following EAE induction, when both groups display comparable clinical scores (i.e., days 7 and 14 post induction). The numbers of cytokine + CD4 T cells in the draining inguinal lymph nodes were slightly elevated, although they did not reach statistical significance (Fig. S4) . Thus, these results suggest that IL-27 signaling in Foxp3 + Tregs may play a more critical role in controlling effector T-cell responses at the target tissue sites.
The Role of IL-27 in Foxp3
+ Tregs. Tregs in the peripheral and CNS tissues of Treg ΔIl27ra mice with EAE were more abundant than those of Treg WT mice, suggesting that the inability of Il27ra −/− Tregs to control the inflammation is likely due to defects in Treg functions rather than to Treg trafficking (Fig. 3A) . Annexin-V binding of Tregs was similar between the groups, suggesting that Il27ra −/− Tregs do not exhibit defects in survival. Consistent with Treg numbers, Foxp3 mRNA expression was greater in the CNS tissues of Treg ΔIl27ra mice (Fig. 3B) . Immunohistochemical analysis further demonstrated comparable infiltration of Foxp3 + Tregs in the CNS regardless of IL-27Rα expression (Fig. 3C) . The expression of Treg markers, such as CTLA4, CD25, and CD39, was indistinguishable between Treg WT and Treg ΔIl27ra mice. Under inflammatory conditions Tregs often express proinflammatory cytokines and acquire pathogenic function (18) . However, Foxp3 (YFP) + Treg expression of IFNγ and IL-17 was similar in both groups (Fig. 3D) . Treg-derived IL-10 is considered a key mediator of Treg function (19) . However, we found that the number of IL-10 + Tregs in Treg ΔIl27ra mice was even greater than that of Treg mice ( Fig. 3 E and H) , suggesting that the IL-27-induced Treg suppressive function may be IL-10-independent (13). Consistent with the FACS data, Ifng, Il17a, Il10, and Il27a mRNA expression of the CNS tissues was significantly elevated in Treg ΔIl27ra mice (Fig. 3F) . T-cell Ig and mucin domain-3 (TIM-3, Havcr2) is an inhibitory receptor expressed on IFNγ-producing CD4 T cells and implicated in suppressing effector T-cell function during autoimmune inflammation (20) . IL-27 stimulation has previously been shown to induce Tim-3 in activated T cells (21) . Havcr2 mRNA expression remained higher in the CNS tissues of Treg ΔIl27ra mice (Fig. 3F) . However, surface Tim-3 expression on Tregs was comparable between the groups (Fig. 3G) , suggesting that Tim-3 is not likely involved in IL-27-dependent Treg function. We previously reported that IL-27 induces the lymphocyte-activating gene 3 (Lag3) in Tregs and that Lag3 expression on Tregs is essential in mediating Treg function during intestinal inflammation in an IL-10-independent manner (13). Indeed, surface Lag3 expression on CNS infiltrating Foxp3 + Tregs was significantly lower in Treg ΔIl27ra mice, while CNS infiltrating effector CD4 T cells expressed comparable levels of Lag3 (Fig. 3H and Fig. S5 ). Overexpression of Lag3 in Tregs using a retroviral vector dramatically enhanced the Treg-suppressive function (Fig. 3I) (Fig. 4A) . Interestingly, we noted that a substantial proportion of tdTomato + cells lost YFP expression, an indication of exTregs (Fig. 4B) . Moreover, the level of exTregs generated was greater in the absence of IL-27Rα expression on Tregs (Fig. 4B) . The absolute numbers of both Tregs and exTregs remained higher in Rosa26 LSL-tdTomato Treg ΔIl27ra mice, and the ratio of exTregs to Tregs was greater in Rosa26 LSL-tdTomato Treg ΔIl27ra mice (Fig. 4C) . Regardless of IL-27Rα expression, exTregs expressed inflammatory cytokines, and the proportions of IFNγ and IL-17-expressing exTregs were even greater than those of effector CD4 T cells (Fig. 4D) . Of note, the absolute numbers of IFNγ-and IL-17-producing effector T cells and exTregs were significantly higher in Rosa26 LSL-tdTomato Treg ΔIl27ra than in Treg WT mice (Fig. 4E) . Thus, IL-27 signaling in Tregs may directly control Treg stability, or alternatively, exTreg generation may be elevated simply due to severe inflammatory conditions in Treg ΔIl27ra mice.
Recombinant IL-27 Administration Has Little Therapeutic Impact in Treg
ΔIl27ra Mice. Unlike the previous findings that IL-27 reverses autoimmunity by inducing IL-10-producing Foxp3 − CD4 cells (12, 21) , our reports thus far demonstrate that IL-27 signaling in Foxp3 + Tregs is instrumental in controlling tissue inflammation. Recombinant rIL-27 administration prevents the development of encephalitogenic effector cell generation and suppresses active EAE (23). We thus tested whether rIL-27 has a therapeutic Each symbol represents an individually tested mouse. The results are representative of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
impact on ongoing EAE in Treg
ΔIl27ra mice. If IL-27-induced IL-10-producing conventional CD4 T cells are critical for this protection, those mice will develop attenuated disease. However, if IL-27 signaling in Tregs is indispensable, those mice will not be protected from the disease. Osmotic pumps containing rIL-27 were implanted at the onset of the disease (on day 8 post immunization). As previously reported (23), rIL-27 administered attenuated ongoing EAE in Treg WT mice compared with the sham group (Fig. 5A ). CD4 T cells producing IFNγ or IL-17 were significantly reduced in IL-27-treated Treg WT mice compared with the sham Treg WT group (Fig. 5B) . On the other hand, the therapeutic effect of IL-27 was not evident in Treg ΔIl27ra mice as rIL-27-treated animals still developed severe EAE (Fig. 5A) . Furthermore, the numbers of effector CD4 T cells producing IFNγ or IL-17 accumulated in the CNS remained higher despite rIL-27 treatment in Treg ΔIl27ra mice (Fig. 5B) . IL-27 can induce IL-10 production in T cells (10) . IL-10 + CD4 T cells in the CNS tissues were elevated in rIL-27-treated mice, although the difference was not statistically different (Fig. 5C) . Moreover, the numbers of IL-10 + CD4 T cells were comparable between Treg WT and Treg ΔIl27ra mice treated with IL-27 (Fig. 5C ). Finally, we tested whether the rIL-27 treatment effect is dependent on IL-10. B6 mice induced for EAE were treated with a rIL-27 pump as described above. Neutralizing anti-IL-10 mAb and blocking anti-IL-10R mAb were simultaneously injected into the treated groups. Antibody treatment did not abrogate the IL-27-mediated treatment effects (Fig. 5D) , suggesting that the protection is IL-10-independent. Therefore, Treg-specific IL-27Rα deficiency appears to be responsible for the lack of treatment effect of IL-27.
Discussion
In earlier studies, susceptibility of Il27ra −/− mice to EAE was attributed to increased generation of IL-17 + CD4 T cells (12) . Suppressive functions of Il27ra −/− Tregs measured in vitro remained intact. It was thus concluded that IL-27 acting on conventional effector T cells suppresses the generation of encephalitogenic Th17-type CD4 T cells (12) . The loss of IL-27 Each symbol represents an individually tested mouse. Mean ± SD from two to three independent experiments is shown. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. also results in enhanced pathology characterized by altered T-cell responses during infections (17, 24) . In the current study, we show that IL-27 signaling in Foxp3 + Tregs is indispensable for Treg function to control autoimmune inflammation in the CNS. Analogous to Il27ra −/− mice, Treg-specific Il27ra −/− mice developed severe EAE. CNS-infiltrating CD4 T cells displaying proinflammatory Th1/Th17 phenotypes were increased. Despite the severe disease in Treg-specific Il27ra −/− mice, CD4 T cells expressing IL-10 were abundant and the IL-10 level in the CNS homogenates was comparable. Systemic rIL-27 administration did not attenuate ongoing EAE when Tregs lacked IL-27Rα. Since conventional CD4 T cells express functional IL-27Rα under this condition, these results strongly suggest that IL-27 plays a nonredundant role in Treg functions to control autoimmune inflammation irrespective of IL-10 + conventional T cells. The precise mechanisms by which IL-27 controls in vivo Treg function need further investigation. We recently found that Lag3 expression on Tregs is necessary for optimal Treg-suppressive function (13) . Lag3 is one of the molecules highly up-regulated by IL-27 stimulation in Tregs (13, 17) , and Lag3 −/− Tregs are partially impaired in preventing T-cell-induced colitis (13) , suggesting that Lag3 expression on Tregs induced in part via IL-27 stimulation may be critical for Tregs to control inflammation. In support of this possibility, Lag3 expression of Tregs but not of Foxp3 − CD4 T cells in the inflamed CNS tissues was significantly lower in Tregspecific Il27ra −/− mice. Furthermore, Lag3 overexpression in Tregs was sufficient to improve their suppressive function, supporting a potential contribution of Lag3 to Treg functions. Unlike conventional CD4 T cells, in which Lag3 inhibits TCR signaling and T-cell activation (25) , Lag3 may play a distinct role in Tregs by promoting Treg functions. It is also possible that Lag3 may inactivate APC function by engaging its ligand, MHCII, and inhibiting immune responses (26) .
While IL-10 produced by conventional CD4 T cells has been implicated in the regulation of autoimmunity, IL-10 fails to control Th17-biased EAE (27) . We similarly observed that the level of IL-10 + conventional CD4 T cells is comparable or even greater in Treg ΔIl27ra mice that develop severe inflammation even after systemic rIL-27 administration. It is thus possible that IL-27 signaling in Tregs may be critical especially in limiting encephalitogenic Th17 immune responses, after which IL-10 + conventional CD4 T cells may acquire regulatory functions to limit "Th1-type" responses. When Tregs are unable to receive IL-27 signals, "Th17-type" effector cells become resistant to IL-10, resulting in uncontrolled disease.
The finding that more Foxp3-exTregs accumulate in the inflamed tissues of Treg ΔIl27ra mice led us to conclude that IL-27 signaling in Tregs may control Treg stability. IL-27 signaling may induce factors that prevent Tregs from losing Foxp3 expression or that interfere with the action of inflammatory mediators that destabilize the Treg phenotypes (2). However, we found it interesting that the frequency of exTregs in the current study is rather high, considering that exTregs usually occur at a low frequency. Are these cells genuine exTregs? This becomes an important question of future investigation as exTregs may arise from activated conventional effector cells that "transiently" express Foxp3, during which they lose IL-27Rα (28) . The precise origin of the exTreg phenotype cells during autoimmune inflammation remains to be carefully determined.
There is increasing evidence that IL-27 has broader effects in Treg homeostasis (5) . IL-27 regulates Treg expansion by controlling IL-2 production (29) . It promotes the emergence of a T-bet + , CXCR3 + Treg subset that suppresses parasite-specific effector responses at the sites of inflammation (17) . IL-27 is also capable CTLA-4/CTLA-4 expression in collagen-induced arthritis (30) , although the lack of IL-27R does not affect their expression under steady-state conditions (13) . IL-27 induces multiple factors including chemokines (CCL3 and CCL4) in Tregs (13) . It was recently shown that chemokines (especially CCL3 and CCL4) produced by Tregs play a key role in attracting pathogenic T cells for better suppression (31) . Therefore, IL-27 may provide an upstream signal that attracts effector T cells to the proximity and subsequently potentiates Treg suppression via a contact-dependent mechanism, possibly through Lag3. IL-27 enhances IL-10 expression by Tregs; however, we previously reported that IL-10 secretion by Tregs is dispensable for Treg suppression of effector T-cell proliferation and cytokine production in a model of colitic inflammation (13) . Indeed, IL-10 expression by Tregs is not altered by functionally defective Il27ra −/− Tregs, suggesting that an alternative mechanism rather than IL-10 production may be more crucial for IL-27-dependent Treg functions (27) . IL-27 induces T-cell expression of TIM-3, an inhibitory receptor that interacts with its ligand, galectin-9, to suppress T-cell function (32) . However, we found no evidence that IL-27 stimulation induces TIM-3 expression in Foxp3 + Tregs. A naturally occurring soluble form of IL-27Rα binds IL-27 and acts as a natural IL-27 antagonist (33). However, we think it unlikely as this should affect IL-27 signaling on all T-cell types in Treg WT and Treg ΔIl27ra groups. Treg functions can be compromised by inflammatory mediators, and such defective Treg functions can contribute to the manifestation of the diseases (34, 35) . Our findings provide a rationale to use IL-27 as a tool to target Tregs to improve Tregmediated regulation of chronic inflammation seen in autoimmune diseases including multiple sclerosis.
Methods
Mice. B6 and B6
LSL-tdtomato (B6-Gt(Rosa)26Sor tm9(CAG-tdTomato)/J ) mice were purchased from the Jackson Laboratory. Germline B6 Il27ra −/− mice were obtained from Amgen. Foxp3 CreYFP mice were purchased from the Jackson Laboratory. Generation of mice carrying floxed Il27ra alleles was carried out as follows. A targeting vector was constructed by cloning fragments of the Il27ra gene amplified from a bacterial artificial chromosome library into a pNLF vector. A neomycin resistance gene cassette flanked by FRT sites was located 3′ of the targeted exons 7 and 8, which are also flanked by two LoxP sites. An expression cassette for the diphtheria toxin A chain was placed 3′ of the construct to negatively select homologous recombination. Murine The results shown are the mean ± SD of two to three independent experiments. (D) B6 mice (n = 5) were induced for EAE, and an osmotic pump containing IL-27 was implanted as described above. Anti-IL-10/anti-IL-10R mAbs (250 μg each) or control Ab was injected every 3 d. The development of EAE was monitored. *P < 0.05; **P < 0.01; ***P < 0.001.
